CD8A and sarcoma: To examine how the CD8+ T cell abundance in primary and transplant tumors compared to the various sarcoma immune classes in patient tumors, we performed CIBERSORTx analysis on human TCGA data and untreated primary and transplant murine p53/MCA sarcomas.